Pronto disponible para inscripción
This study will open for enrollment soon. Please contact the study team for more information and check back frequently.

KiteLock in Kids with CVC - Clinical Trial

¿Cuál es el Propósito de este estudio?

Some kids need a special tube called a central line to get medicine and food. But when the tube isn't being used, it can get blocked or infected. To help stop this, doctors use a liquid called a locking solution.

In this study, kids will be randomly placed into one of two groups:

- Group 1 will use the regular locking liquid called heparin.

- Group 2 will use a new liquid called Kitelock.

Both groups will use their locking liquid every day. They'll also have check-ups, blood tests, and keep a daily diary. The study will last about 1 year and include 6 in-person visits and 10 phone or video visits.

¿Cuál es la Condición que se está estudiando?

PREVENTING CENTRAL VENOUS CATHETER

OCCLUSIONS IN CHILDREN WITH INTESTINAL FAILURE

¿Quién puede participar en el Estudio?

Who can join this study:

- Kids who have a serious stomach problem called intestinal failure and need special nutrition through a tube.

- They must be older than 4 weeks but were diagnosed before turning 18.

- They must have a special kind of tube called a central line, which helps give them medicine and nutrients.

Grupo etario
Niños

¿Qué Implica?

Doctors are doing a study to learn more about a new liquid called KiteLock. It's used to keep special tubes (called central lines) clean and safe for kids who have serious stomach problems and need help getting food and medicine.

KiteLock has something called tetrasodium EDTA in it, and doctors want to see if it works better than the regular liquid called heparin. The goal is to find out which one helps stop clogs and infections in the tubes more safely and effectively.

Detalles del Estudio

Título Completo
Safety And Effectiveness Of 4% Tetrasodium Ethylenediaminetetraacetic Acid Catheter Lock Solution in Preventing Central Venous Catheter Occlusions in Children with Intestinal Failure: A Randomized Controlled Trial
Investigador Principal
Debra L. Sudan, MD
Especialista en cirugía de trasplante de riñón y páncreas
Número de Protocolo
IRB: PRO00118105
NCT: NCT05879835
Fase
Fase N/A
ClinicalTrials.gov
Estado de inscripción
Pronto disponible para inscripción
Apoye las investigaciones de Duke Health o honre a un ser querido con un regalo de homenaje.